Published on
updated on
Reading 2 min.
in collaboration with
Dr Gérald Kierzek (Medical Director)
Medical validation:
August 14, 2024
Have you taken Daflon recently? Be careful, the ANSM has launched a recall procedure for these drugs because they may contain traces of trimetazidine.
Recently, the ANSM was informed of the presence of traces of trimetazidine in a batch of Daflon 500 mg (batch 6068122). The problem? This medicinal substance is not included in the composition of Daflon, but it is used to treat angina in adults. For your health, it is therefore recommended not to take this medication and to return it to the pharmacy.
What is the reference concerned?
According to Servier laboratories and in agreement with the ANSM, boxes of Daflon from batch 6068122 are currently subject to a recall. “Daflon 500 mg is a drug available without a prescription for the treatment of disorders of venous circulation (heavy legspain, and restlessness) and functional signs related to the hemorrhoidal crisis” can be read on the ANSM website.
This medicine is being recalled because traces of trimetazidine have been identified in batch 6068122 of Daflon. According to the laboratory’s analyses of this batch, the very small amounts of trimetazidine found do not pose a risk to patients who may have been exposed to it. Investigations are currently being conducted to determine its origin. Other batches marketed in France are not affected.
What is the correct course of action?
For patients
If you have recently purchased Daflon, check the lot number on the box of your medicine. If a reference other than 6068122 is written on your box, you are not affected by the recall. If in doubt, return the box to your pharmacist who will check the batch number.
If the number matches the recalled reference, return your box to the pharmacy. Your pharmacist will check the batch number of your box and will issue you a new box from another batch. While waiting for your box to be exchanged, your treatment can be safely interrupted.
For pharmacists
You should contact patients who may have the affected lots when possible, to explain the reasons and procedures for the recall. Posters are also provided by the laboratory. If a patient brings you a box of the affected lot 6068122replace the box with a box from another lot of Daflon 500 mg.
As Dr. Kierzek, emergency physician and medical director of Doctissimo, reminds us:There is no risk in stopping Daflon and the very small amounts of trimetazidine detected do not present any health hazard either. A simple precautionary principle therefore“.
Slideshow: My natural summer medicine kit